Mapping the Future of Particle Radiobiology in Europe: The INSPIRE Project

0534275 - ÚJF 2021 RIV CH eng J - Článek v odborném periodiku
Henthorn, N. T. - Sokol, O. - Durante, M. - De Marzi, L. - Pouzoulet, F. - Misczcyk, J. - Olko, P. - Brandenburg, S. - Goethem, M. J. - Barazzuol, L. - Tambas, M. - Langendijk, J. A. - Davídková, Marie - Vondráček, V. - Bodenstein, E. - Pawelke, J. - Lomax, A. J. - Weber, D. C. - Dasu, A. - Stenerlöw, B. - Poulsen, P. R. - Sorensen, B. S. - Grau, C. - Sitarz, M. K. - Heuskin, A. C. - Lukas, S. - Wermenhoven, J. W. - Merchant, M. J. - Makay, R. I. - Kirkby, K. J.
Mapping the Future of Particle Radiobiology in Europe: The INSPIRE Project.
Frontiers in Physics. Roč. 8, OCT (2020), č. článku 565055. ISSN 2296-424X. E-ISSN 2296-424X
GRANT EU: European Commission(XE) 730983 - INSPIRE
Institucionální podpora: RVO:61389005
Klíčová slova: proton therapy * radiotherapy * radiobiology * beamtime * irradiation
Obor OECD: Radiology, nuclear medicine and medical imaging
Impakt faktor: 3.560, rok: 2020
Způsob publikování: Open access
https://doi.org/10.3389/fphy.2020.565055

Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a number of unanswered questions considering differences in the biological response between particles and photons. These questions, and probing of biological mechanisms in general, necessitate experimental investigation. The 'Infrastructure in Proton International Research' (INSPIRE) project was created to provide an infrastructure for European research, unify research efforts on the topic of proton and ion therapy across Europe, and to facilitate the sharing of information and resources. This work highlights the radiobiological capabilities of the INSPIRE partners, providing details of physics (available particle types and energies), biology (sample preparation and post-irradiation analysis), and researcher access (the process of applying for beam time). The collection of information reported here is designed to provide researchers both in Europe and worldwide with the tools required to select the optimal center for their research needs. We also highlight areas of redundancy in capabilities and suggest areas for future investment.
Trvalý link: http://hdl.handle.net/11104/0312497